COMMUNIQUÉS West-GlobeNewswire

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
24/02/2026
FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company [...]
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
23/02/2026
WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
23/02/2026
FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, taxane-naïve metastatic castration-resistant prostate cancer (mCRPC), led to a [...]
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
23/02/2026
Dallas, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform [...]
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
23/02/2026
Generated full-year 2025 net product sales of XDEMVY ® of $451.4 million , an increase of more than 150% year-over-year Providing expected XDEMVY peak sales potential of more than $2 billion Extending category-creating [...]
Supernus Pharmaceuticals to Participate in March Investor Conferences
24/02/2026
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
23/02/2026
Strategic reset positions Galapagos for long-term value creation Robust 2025 year-end cash and financial investments of €3.0 billion and ongoing collaboration with Gilead enable flexibility to execute on a business [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
23/02/2026
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living [...]
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations
23/02/2026
Webcast conference call to take place tomorrow, Tuesday, February 24, 2026, at 8:00am ET WAYNE, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics , Inc. (Palvella or “the Company”), a clinical- [...]
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
23/02/2026
SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in [...]
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
23/02/2026
Reported rinzimetostat (formerly ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with [...]
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
23/02/2026
CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity [...]
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
23/02/2026
VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced Cary Vance, [...]
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Enspire Dental Marks Full Transition to Woman-Owned Private Practice Amid Rising Cosmetic Dentistry Demand in Ann Arbor
23/02/2026
Patients increasingly seek cosmetic dentistry, blending confidence with oral health at Enspire Dental. Ann Arbor, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Enspire Dental, a family and general dentistry practice in Ann Arbor, [...]
Foundation for Sarcoidosis Research Receives 2025 RareVoice Award for Federal Advocacy During Rare Disease Month
23/02/2026
CHICAGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) has been named a 2025 RareVoice Awards recipient by EveryLife Foundation for Rare Diseases , earning national recognition for [...]
RESTEM to Present at BIO Investment & Growth Summit 2026
23/02/2026
MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, [...]
Pixel Health Launches One Thread™, an AI-Powered Experience Layer for Unified Patient Access and Engagement
23/02/2026
A collaborative go-to-market approach with Praia Health that accelerates digital front door transformation while keeping health systems in control of their strategy and brand. HOLYOKE, Mass., Feb. 23, 2026 (GLOBE [...]
Cylinder Health and Stonebrook Risk Solutions announce strategic partnership to strengthen digestive disease management
23/02/2026
The collaboration expands Stonebrook’s specialty ecosystem with a virtual-first digestive health center of excellence delivering coordinated care across the full spectrum of GI conditions CHICAGO, Feb. 23, 2026 (GLOBE [...]

Pages